Are you currently developing purification processes for antibody fragments?
Do you use both resins and membrane-based technology for chromatography?
Does your organization leverage platform technologies for monoclonal antibody purification?
To what extent has your organization adopted continuous chromatography?
To what extent has QbD been applied to your chromatography operations?
- About Us
- Current Topic
- Topic #1: “Breaking the Bottleneck…”
- Topic #2: Challenges of Multi-Product Facilities
- Topic #3: What’s in Your Column: Irregular or Spherical?
- Topic #4: “Applying the Principles of QbD…”
- Topic #5: Is Continuous Chromatography the Answer?
- Topic #6: Platform Technologies
- Topic #7: Membrane versus Resin-based Chromatography
- Topic #8: Trends in the Purification of Antibody Fragments
- Stay Connected